Top

BMC Urology

Published in:

Open Access 01-12-2014 | Research article

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy

Authors: Michael Froehner, Anna-Elisa Kellner, Rainer Koch, Gustavo B Baretton, Oliver W Hakenberg, Manfred P Wirth

Published in: BMC Urology | Issue 1/2014

Abstract

Background

In patients with early prostate cancer, stratification by comorbidity could be of importance in clinical decision making as well as in characterizing patients enrolled into clinical trials. In this study, we investigated several comorbidity classifications as predictors of overall mortality after radical prostatectomy, searching for measures providing complementary prognostic information which could be combined into a single score.

Methods

The study sample consisted of 2205 consecutive patients selected for radical prostatectomy with a mean age of 64 years and a mean follow-up of 9.2 years (median: 8.6). Seventy-four patients with incomplete tumor-related data were excluded. In addition to age and tumor-related parameters, six comorbidity classifications and the body mass index were assessed as possible predictors of overall mortality. Kaplan-Meier curves and Mantel-Haenszel hazard ratios were used for univariate analysis. The impact of different causes of death was analyzed by competing risk analysis. Cox proportional hazard models were calculated to analyze combined effects of variables.

Results

Age, Gleason score, tumor stage, Charlson score, American Society of Anesthesiologists (ASA) physical status class and body mass index were identified a significant predictors of overall mortality in the multivariate analysis regardless whether two-sided and three-sided stratifications were used. Competing risk analysis revealed that the excess mortality in patients with a body mass index of 30 kg/m² or higher was attributable to competing mortality including second cancers, but not to prostate cancer mortality.

Conclusion

Stratifying patients by a combined consideration of the comorbidity measures Charlson score, ASA classification and body mass index may assist clinical decision making in elderly candidates for radical prostatectomy.

Available only for authorised users

Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF: Differential prognostic impact of comorbidity. J Clin Oncol. 2004, 22: 3099-3103. 10.1200/JCO.2004.08.040.CrossRefPubMed

Cooperberg MR, Broering JM, Carroll PR: Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol. 2010, 28: 1117-1123. 10.1200/JCO.2009.26.0133.CrossRefPubMedPubMedCentral

Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G: Is there an optimal comorbidity index for prostate cancer?. Cancer. 2008, 112: 1043-1050. 10.1002/cncr.23269.CrossRefPubMed

Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW, Han M: Prediction of mortality after radical prostatectomy by Charlson comorbidity index. Urology. 2010, 76: 553-557. 10.1016/j.urology.2010.02.069.CrossRefPubMedPubMedCentral

Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, Litwin MS: Improved prediction of long-term, other cause mortality in men with prostate cancer. J Urol. 2011, 86: 1868-1873.CrossRef

Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed

Briganti A, Spahn M, Joniau S, Gontero P, Bianchi M, Kneitz B, Chun FK, Sun M, Graefen M, Abdollah F, Marchioro G, Frohneberg D, Giona S, Frea B, Karakiewicz PI, Montorsi F, Van Poppel H, Jeffrey Karnes R, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT): Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: A multi-institutional competing-risks analysis. Eur Urol. 2013, 63: 693-701. 10.1016/j.eururo.2012.08.054.CrossRefPubMed

American Society of Anesthesiologists: ASA physical status classification system. Available from: http://www.asahq.org/clinical/physicalstatus.htm (accessed March 13, 2014)

The Criteria Committee of the New York Heart Association: Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 1994, Boston: Mass: Little, Brown & Co, 253-256. 9

10.

Kaul P, Naylor CD, Armstrong PW, Mark DB, Theroux P, Dagenais GR: Assessment of activity status and survival according to the Canadian Cardiovascular Society angina classification. Can J Cardiol. 2009, 25: e225-e231. 10.1016/S0828-282X(09)70506-9.CrossRefPubMedPubMedCentral

11.

Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van den Berg HA, Coebergh JW: Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol. 2006, 58: 60-67. 10.1016/j.critrevonc.2005.08.003.CrossRefPubMed

12.

Pintilie M: Competing risks: a practical perspective. 2006, Chichester, England, Hoboken, NJ: John Wiley & Sons, 195-207.CrossRef

13.

Sandhu GS, Andriole GL: Overdiagnosis of prostate cancer. J Natl Cancer Inst Monogr. 2012, 45: 146-151.CrossRef

14.

Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, Mason MD, Matveev V, Mottet N, van der Kwast TH, Wiegel T, Zattoni F: EAU guidelines on prostate cancer. Update 2013. Available from: http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf (accessed March 13, 2014)

15.

Froehner M, Koch R, Litz RJ, Hakenberg OW, Wirth MP: Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?. BJU Int. 2012, 110: 206-210. 10.1111/j.1464-410X.2011.10693.x.CrossRefPubMed

16.

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003, 348: 1625-1638. 10.1056/NEJMoa021423.CrossRefPubMed

17.

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF: Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006, 355: 763-778. 10.1056/NEJMoa055643.CrossRefPubMed

18.

Flegal KM, Kit BK, Orpana H, Graubard BI: Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013, 309: 71-82. 10.1001/jama.2012.113905.CrossRefPubMedPubMedCentral

19.

Siddiqui SA, Inman BA, Sengupta S, Slezak JM, Bergstralh EJ, Leibovich BC, Zincke H, Blute ML: Obesity and survival after radical prostatectomy: a 10-year prospective cohort study. Cancer. 2006, 107: 521-529. 10.1002/cncr.22030.CrossRefPubMed

20.

Nguyen PL, Chen MH, Beard CJ, Suh WW, Choueiri TK, Efstathiou JA, Hoffman KE, Loffredo M, Kantoff PW, D’Amico AV: Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence. Cancer. 2010, 116: 610-615. 10.1002/cncr.24818.CrossRefPubMed

21.

Capitanio U, Pellucchi F, Gallina A, Briganti A, Suardi N, Salonia A, Abdollah F, Di Trapani E, Jeldres C, Cestari A, Karakiewicz PI, Montorsi F: How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. BJU Int. 2011, 107: 1095-1101. 10.1111/j.1464-410X.2010.09580.x.CrossRefPubMed

22.

Froehner M, Koch R, Wirth MP: Re: Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM: Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol. 2013, 62: 662-70. Eur Urol 2013, 63: e9

23.

Boorjian SA, Kim SP, Tollefson MK, Carrasco A, Cheville JC, Thompson RH, Thapa P, Frank I: Comparative performance of comorbidity indices for estimating perioperative and 5-Year all-cause mortality following radical cystectomy for bladder cancer. J Urol. 2013, 190: 55-60. 10.1016/j.juro.2013.01.010.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/14/28/prepub

Title: A combined index to classify prognostic comorbidity in candidates for radical prostatectomy
Authors: Michael Froehner
Anna-Elisa Kellner
Rainer Koch
Gustavo B Baretton
Oliver W Hakenberg
Manfred P Wirth
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Urology / Issue 1/2014
Electronic ISSN: 1471-2490
DOI: https://doi.org/10.1186/1471-2490-14-28

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A combined index to classify prognostic comorbidity in candidates for radical prostatectomy

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

The postoperative morbidity index: a quantitative weighing of postoperative complications applied to urological procedures

Is there a role for anterior zone sampling as part of saturation trans-rectal ultrasound guided prostate biopsy?

Effectiveness of preoperative pelvic floor muscle training for urinary incontinence after radical prostatectomy: a meta-analysis

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid

Robotic radical nephrectomy for renal cell carcinoma: a systematic review

Hem-O-Lok clip: a neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy